Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank58
5Y CAGR-31.9%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
-31.9%/yr
Long-term compound
Percentile
P58
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 21.49% |
| 2024 | 12.21% |
| 2023 | 3.75% |
| 2022 | -13.78% |
| 2021 | -8.20% |
| 2020 | 146.78% |
| 2019 | 91.24% |
| 2018 | 11.75% |
| 2017 | 563.91% |
| 2016 | -28.14% |